» Articles » PMID: 36759929

Immunogenicity of Decellularized Extracellular Matrix Scaffolds: a Bottleneck in Tissue Engineering and Regenerative Medicine

Overview
Journal Biomater Res
Date 2023 Feb 10
PMID 36759929
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue-engineered decellularized extracellular matrix (ECM) scaffolds hold great potential to address the donor shortage as well as immunologic rejection attributed to cells in conventional tissue/organ transplantation. Decellularization, as the key process in manufacturing ECM scaffolds, removes immunogen cell materials and significantly alleviates the immunogenicity and biocompatibility of derived scaffolds. However, the application of these bioscaffolds still confronts major immunologic challenges. This review discusses the interplay between damage-associated molecular patterns (DAMPs) and antigens as the main inducers of innate and adaptive immunity to aid in manufacturing biocompatible grafts with desirable immunogenicity. It also appraises the impact of various decellularization methodologies (i.e., apoptosis-assisted techniques) on provoking immune responses that participate in rejecting allogenic and xenogeneic decellularized scaffolds. In addition, the key research findings regarding the contribution of ECM alterations, cytotoxicity issues, graft sourcing, and implantation site to the immunogenicity of decellularized tissues/organs are comprehensively considered. Finally, it discusses practical solutions to overcome immunogenicity, including antigen masking by crosslinking, sterilization optimization, and antigen removal techniques such as selective antigen removal and sequential antigen solubilization.

Citing Articles

The application of tissue engineering strategies for uterine regeneration.

Chen S, Yoo J, Wang M Mater Today Bio. 2025; 31:101594.

PMID: 40070871 PMC: 11894340. DOI: 10.1016/j.mtbio.2025.101594.


Advancing Heart Valve Replacement: Risk Mitigation of Decellularized Pulmonary Valve Preparation for Its Implementation in Public Tissue Banks.

Rodriguez Martinez J, Castells-Sala C, Baptista Piteira A, Montagner G, Trojan D, Martinez-Legazpi P Ther Clin Risk Manag. 2025; 21:209-228.

PMID: 40035073 PMC: 11873323. DOI: 10.2147/TCRM.S486508.


Towards Safety and Regulation Criteria for Clinical Applications of Decellularized Organ-Derived Matrices.

van Hengel E, van der Laan L, De Jonge J, Verstegen M Bioengineering (Basel). 2025; 12(2).

PMID: 40001655 PMC: 11851377. DOI: 10.3390/bioengineering12020136.


T-PRP-DAT Gel: A Novel Material Promotes Adipose Tissue Regeneration.

Hou M, Tang J, Guo Y, Peng H, Liang B, Cheng Y J Cosmet Dermatol. 2025; 24(2):e70045.

PMID: 39963070 PMC: 11833427. DOI: 10.1111/jocd.70045.


Decellularized Liver Matrices for Expanding the Donor Pool-An Evaluation of Existing Protocols and Future Trends.

Morawski M, Krasnodebski M, Rochon J, Kubiszewski H, Marzecki M, Topyla D Biomolecules. 2025; 15(1).

PMID: 39858491 PMC: 11762870. DOI: 10.3390/biom15010098.


References
1.
Wood K, Goto R . Mechanisms of rejection: current perspectives. Transplantation. 2011; 93(1):1-10. DOI: 10.1097/TP.0b013e31823cab44. View

2.
White L, Taylor A, Faulk D, Keane T, Saldin L, Reing J . The impact of detergents on the tissue decellularization process: A ToF-SIMS study. Acta Biomater. 2016; 50:207-219. PMC: 5592694. DOI: 10.1016/j.actbio.2016.12.033. View

3.
Willemse J, Verstegen M, Vermeulen A, Schurink I, Roest H, van der Laan L . Fast, robust and effective decellularization of whole human livers using mild detergents and pressure controlled perfusion. Mater Sci Eng C Mater Biol Appl. 2020; 108:110200. DOI: 10.1016/j.msec.2019.110200. View

4.
Londono R, Dziki J, Haljasmaa E, Turner N, Leifer C, Badylak S . The effect of cell debris within biologic scaffolds upon the macrophage response. J Biomed Mater Res A. 2017; 105(8):2109-2118. DOI: 10.1002/jbm.a.36055. View

5.
Holl J, Pawlukianiec C, Corton Ruiz J, Groth D, Grubczak K, Hady H . Skin Substitute Preparation Method Induces Immunomodulatory Changes in Co-Incubated Cells through Collagen Modification. Pharmaceutics. 2021; 13(12). PMC: 8705760. DOI: 10.3390/pharmaceutics13122164. View